Virtual reality program for breast cancer patients returning to work
Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
This study tests a virtual reality program to help breast cancer patients with cognitive difficulties get back to work more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 23 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Francois Baclesse Academic / other |
| Drugs / interventions | Trastuzumab, chemotherapy |
| Locations | 2 sites (Caen and 1 other locations) |
| Trial ID | NCT06267014 on ClinicalTrials.gov |
What this trial studies
This study focuses on breast cancer patients who have experienced cognitive difficulties and are looking to return to or maintain their professional activities. Participants will engage in a Virtual Reality cognitive stimulation program, consisting of weekly sessions lasting 10-15 minutes over a period of six weeks. The program aims to assist these patients in overcoming cognitive challenges related to their cancer treatment. By integrating cognitive rehabilitation with innovative technology, the study seeks to enhance the patients' ability to function in their work environment.
Who should consider this trial
Good fit: Ideal candidates are breast cancer patients over 18 years old who have completed adjuvant chemotherapy within the last two years and are experiencing cognitive complaints.
Not a fit: Patients with severe psychiatric conditions, personality disorders, or those unable to comply with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve cognitive function and work readiness for breast cancer survivors.
How similar studies have performed: While the use of virtual reality in cognitive rehabilitation is an emerging field, similar approaches have shown promise in other patient populations, indicating potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 years of age * Patient with breast cancer for whom adjuvant chemotherapy has been administered; maintenance treatments (e.g. Trastuzumab, hormone therapy) are eligible, * Maximum 2 years after completion of adjuvant treatment, * Patients who have cognitive complaints at inclusion (answer yes to the question: 'Since your cancer treatment, have you had any difficulties with memory, concentration, etc.?) * Patients planning to return to work or who have returned to work in the past year, * Signature of informed consent prior to any specific procedure relating to the study, * Patient affiliated to a social security system. Exclusion Criteria: * Patients suffering from illnesses or conditions that impair their ability to understand, follow and/or comply with study procedures, * Patients with personality disorders and/or psychiatric pathology, * Patients deprived of their liberty or placed under the authority of a guardian, * Pregnant women
Where this trial is running
Caen and 1 other locations
- Centre François Baclesse — Caen, France (Not_yet_recruiting)
- Centre François Baclesse — Caen, France (Recruiting)
Study contacts
- Study coordinator: Adeline MOREL, MD
- Email: a.morel@baclesse.unicancer.fr
- Phone: 33231455050
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.